While Min Hee-jin, former CEO of Adore, resigned from her position as an executive director and left the company, Adore said, “It is unfortunate that the notice was unilateral,” and announced that it would continue to support its group New Genes.
Adore, one of the Hive labels, issued an official statement on the afternoon of the 20th, saying, “We regret the unilateral resignation notice of Director Min Hee-jin,” and added, “We will do our best to support New Genes so that it can grow and develop further.” It was said.
Earlier, on this afternoon, former CEO Min said, “Today, I am resigning as an executive director of Adore.” He added, “I intend to terminate the shareholder contract signed with Hive and hold Hive legally responsible for violations of the shareholder contract.” announced that he would be leaving. He continued, “We plan to take necessary legal action one by one against the numerous illegal activities of Hive and its associates.”
He continued, “Despite the hellish dispute with Hive that started with Hive’s illegal audit last April and has continued for over 7 months, I have done everything I can to keep the shareholder agreement and get Adore back on track as it was before April. “We made every effort possible,” he said, but added, “Hive has not yet acknowledged its mistake and shows no signs of changing, so we have decided that further efforts would be a waste of time.”
Former CEO Min said, “For the past seven months, I have fought with all my might, pouring everything in mentally, economically, and physically to revive Adore, which was ruined due to Hive’s serious violation of the shareholders’ contract.” He added, “A group disguised as a large corporation. “It means that even though it was a hellish fight that started with groundless violence, we did not back down and made every effort,” he said.
He said, “Hive’s moral hazard has already reached its peak and the dirty media play will continue, but I am not worried that it has now reached a point where even the public is reading the pattern.” “I inform you that I will punish you,” he emphasized.
Lastly, he said, “Some people may not understand why I have endured this long, but there may be a reason and meaning for people like me to exist in the world,” and added, “I hope you will pay a lot of attention to the new K-pop journey that I will embark on in the future.” .
Meanwhile, last October, the Seoul Central District Court dismissed former CEO Min Hee-jin’s application for a temporary injunction, including the exercise of voting rights, against Adore’s parent company, Hive. The Adore Board of Directors also rejected the motion related to the ‘appointment of Executive Director Min Hee-jin as CEO’, ultimately frustrating Director Min’s return to the CEO position.
Afterwards, on the 13th, Adore’s group New Jeans sent
a proof of contents to Adore under the real names of Kim Min-ji, Hani Pham, Marsh Daniel, Kang Hae-rin, and Lee Hye-in. Through this, the members reportedly demanded that all serious violations of the exclusive contract be corrected within 14 days, and that if they do not comply, they will terminate the exclusive contract.
(Seoul = News 1)
- I’m angry
- 0dog
- I recommend it
- dog
Hot news now
How might Heejin Min’s departure impact the future of Adore and its artists, particularly New Genes?
Time.news Interview: Examining the Departure of Heejin Min from Adore
Editor: Good day, and welcome to Time.news. Today, we are diving deep into a significant development in the K-pop industry: the recent resignation of Heejin Min, former CEO of Adore. Joining us for this insightful discussion is Dr. Soo-Young Jang, an expert in corporate governance and the music industry. Thank you for being here, Dr. Jang.
Dr. Jang: Thank you for having me. It’s a pleasure to be here.
Editor: Let’s start with the news that has sent ripples through the K-pop community. Heejin Min’s resignation from Adore and her allegations against Hive have raised many eyebrows. What do you think were the underlying issues that led to her departure?
Dr. Jang: Heejin Min’s resignation appears to stem from a complex web of contractual disputes and alleged misconduct by Hive, Adore’s parent company. Her comments about the “illegal audit” and “violations of the shareholder contract” suggest a deep discontent regarding corporate governance within Hive. It seems that Min felt she had exhausted all avenues to resolve these issues internally without any acknowledgment from Hive.
Editor: That’s insightful. In her resignation statement, she mentioned a “hellish fight” and highlighted her commitment to reviving Adore. Why do you think she chose to battle for so long despite the apparent challenges?
Dr. Jang: Min’s persistence can be interpreted as a blend of professional dedication and personal conviction. She likely believed in the potential of Adore and its artists, especially New Genes, which is a significant part of the label’s identity. Moreover, her fight hints at a larger battle against perceived injustices within the corporate structure of K-pop, which can often prioritize profitability over artistic integrity.
Editor: You mentioned New Genes, and it’s clear that Min intended to protect the interests of the label and its artists. Adore has publicly stated its commitment to support New Genes moving forward. How crucial is leadership stability for a label’s success in this competitive industry?
Dr. Jang: Leadership stability is paramount in the K-pop industry, where brand identity and artist development are tightly interwoven with the vision of the label’s executives. Frequent changes in leadership can lead to uncertainty, impacting the morale of artists and staff. In this case, the public support from Adore for New Genes is essential to maintain confidence among fans and stakeholders during this transition.
Editor: During her statement, Min hinted at future legal action against Hive. How do you foresee this affecting the relationship between the two entities moving forward?
Dr. Jang: Legal battles can be quite contentious and often lead to a prolonged toxic environment. If Min follows through on her intentions to pursue legal action, it could further strain relationships and draw public scrutiny. This might not only affect Hive and Adore’s operational dynamics but could also impact the artists if tensions escalate or if internal conflicts distract from artistic endeavors.
Editor: In light of the controversies surrounding Min and Hive, what lessons can other companies in the K-pop industry learn from this situation?
Dr. Jang: Transparency and good governance are essential. Companies must ensure that contracts are clear and respected, and that they have a mechanism to address grievances constructively. Cultivating an atmosphere of open communication can prevent disputes from escalating to the level we’ve seen with Min and Hive. Furthermore, the mental and emotional well-being of executives should not be overlooked, as leadership stress can have ripple effects throughout the organization.
Editor: as Min embarks on a new journey in her career, what can the industry expect from her initiatives moving forward?
Dr. Jang: Given Min’s experience and tenacity, it’s likely that she will continue to be a significant player in the K-pop industry. If she focuses on building an artist-centered approach free from the constraints she faced at Hive, we may see innovative projects that align more closely with the artists’ visions. Her past actions indicate that she’s driven by a strong desire to establish a more ethically sound and artistically rich environment, which could resonate well with fans and creators alike.
Editor: Thank you, Dr. Jang, for your valuable insights into this unfolding situation. It’s clear that Heejin Min’s resignation opens up many questions about governance and leadership in the K-pop scene. We’ll be watching closely as this story develops.
Dr. Jang: Thank you for having me. It’s an important discussion, and I look forward to seeing how it unfolds.
Editor: That wraps up our interview. Thank you for tuning in to Time.news. Stay tuned for more updates on the evolving dynamics in the world of K-pop.